These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15041386)

  • 1. Follow-up study of renal transplant recipients treated at the Guatemalan Social Security Hospital.
    Sánchez-Polo V; Lou-Meda R; Castillo M; Herrera C; Mollinedo A
    Transplant Proc; 2004 Mar; 36(2 Suppl):454S-455S. PubMed ID: 15041386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function.
    Domínguez J; Fuenzalida D; Norambuena R; Pais E; Cortes Monroy G; Llanos R
    Transplant Proc; 2005 Apr; 37(3):1583-5. PubMed ID: 15866680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of C2 measurement on cyclosporine Neoral dosing in a Latin-American transplant program: the Guatemalan experience.
    García-Gallont R; Toledo Solares M
    Transplant Proc; 2004 Mar; 36(2 Suppl):451S-453S. PubMed ID: 15041385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience.
    Li JT; Danguilan RA; Cabanayan-Casasola CB; Talusan-Tomacruz Y; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
    Ichikawa Y; Kishikawa H; Nishimura K; Tokugawa S; Yoshioka I; Arichi N; Fujii N; Kyo M; Nishikawa M
    Transplant Proc; 2006 Dec; 38(10):3451-3. PubMed ID: 17175300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.
    Nart A; Sipahi S; Aykas A; Uslu A; Hoşcoşkun C; Toz H
    Transplant Proc; 2008; 40(1):189-92. PubMed ID: 18261583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M; Morales JM; Marcen R; Campistol JM; Oppenheimer F; Serón D; Gil-Vernet S; Capdevila L; Andrés A; Lampreave I; Del Castillo D; Cabello M; Burgos D; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
    Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
    Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J
    Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pediatric renal transplantation: clinical analysis of 23 cases].
    Chen JH; Shen W; He Q; Jiang R; Peng WH
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1100-3. PubMed ID: 15498295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of early adequate exposure to cyclosporine in renal transplant outcome: study of 1-year creatinine.
    Dominguez J; Kompatzki A; Velasco A; Turpaud F; Norambuena R; Arenas J; Pais E; Llanos R; Cortes-Monroy G
    Transplant Proc; 2005 Oct; 37(8):3358-60. PubMed ID: 16298595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.